Velico, Inc. has launched a groundbreaking collaboration with the South Texas Blood and Tissue Center (STBT), a subsidiary of San Antonio-based ...

Aescuvest Capital Partners (ACP) is at the forefront of Healthtech investing, leveraging its deep expertise in European ...

Big developments are expected this week at the 2025 ASCO Gastrointestinal Cancers Symposium, running January 23-25 in San Francisco. This year's event is particularly critical as researchers highlight ...

Axsome Therapeutics (AXSM) announced that the U.S. FDA has approved Symbravo for the acute treatment of migraine with or without aura in ...

as determined by a Food and Drug Administration (FDA)-approved test, that has progressed on one or more endocrine therapies in the metastatic setting. ENHERTU is a specifically engineered HER2 ...

Brenner replaces Dr. Robert Califf. The announcement was made quietly via an update made online to the FDA’s leadership bio page. As of Jan. 24 Brenner’s biography had not been added to the page.

The FDA has developed a new strategy to prevent the contamination of fresh and frozen berries with viruses such as hepatitis A and norovirus. “Collaboration between regulators, the global berry ...

Not all chemical hair relaxers include the chemical, but many include ingredients that can release formaldehyde when heated, the FDA said in 2024. Over the years, an increasing number of studies ...

Jan 28 (Reuters) - The U.S. FDA has approved Novo Nordisk's (NOVOb.CO), opens new tab Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart ...

Share on Pinterest The FDA has approved an esketamine nasal spray for the treatment of depression cases that do not respond to other therapeutic approaches. Image credit: Koldunov/Getty Images.